Additionally, paste this code immediately after the opening tag:

Order a free catalogue!









SiDLY on European Startup Day

On May 11, Michał Pizon, co-founder of SiDLY, was pleased to represent the Polish medical startup scene during the For Human path. Biotechnology, medicine, ecology at European Startup Day.

They were invited to participate in the discussion: Piotr Buszman, deputy director for pre-clinical research, American Heart of Poland Research and Development Center; Barbara Misiewicz-Jagielak, Director of External Relations, Polpharma Group; Sławomir Połukord, senior business development manager, Microsoft; Magdalena Władysiuk, medical technology assessment expert, HTA Consulting, President, Central and Eastern European Society of Technology Assessment in Health Care. 

The discussion allowed the confrontation of mature companies and startups, their opinions about market development, and the needs of micro and macro-organizations. Representatives of mature organizations pointed to the maturity aspect of the business model, and the attractiveness of the project to the end customer, as one of the key drivers for co-operation with startups. Michał Pizon, pointed out among others multifaceted cooperation with corporations on ready-made startups such as SiDLY- from distribution, purchase of startup product, project financing model, or marketing support.


Sidly Ltd. implements a project co-financed from European Funds “Foreign promotion of the Sidly Care multisensory device for remote medical care”

The aim of the project is to increase the competitiveness and visibility of Sidly Ltd. and its innovative product SiDLY Care – a multisensory device for remote medical care in the forms of promotion related to market events specified in the Program for the promotion of the medical equipment industry.

Project value:1 162 350,00 PLN
Co-financing from the European Union: 756 000,00 PLN
Project implementation period: 14.03.2017 – 31.12.2019r.

Project goals – to develop a telemedicine prototype system for continuous heart rate monitoring

Project research results will be implemented in the Company’s operations, and the cardiac dysfunction detection system, developed as part of the project, will be introduced to the Company’s offer next to the current product.

project value: – 3 364 840,00 PLN
contribution of European Funds : – 2 493 088,00 PLN

Website co-financed from the European Regional Development Fund under the Intelligent Development Operational Program 2014-2020, Measure 3.3 “Support for the promotion and internationalization of innovative enterprises”